Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neoplasms, Unknown Primary × Mebendazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Optic Nerve Glioma 1 Neoplasms, Unknown Primary 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Astrocytoma 1

Interventions

Paclitaxel 2 Radiotherapy 1 Mebendazole 1 Fluorouracil 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03628079 2020-01-22

RepoMeb

Repos Pharma

Phase 1/2 Terminated

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡